Adding Radiation to Systemic Therapy Boosts Survival in Advanced Liver Cancer

Adding stereotactic body radiation therapy to sorafenib (Nexavar, Bayer) improves outcomes in patients with advanced hepatocellular therapy. In a study of 193 patients, overall survival was 15.8 months for those who received the combination treatment vs. 12.3 months for sorafenib alone.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ